Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0001707516-26-000015 · wk-form4_1791230743.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,101 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 941 | $94.35 | $88,783.35 |
DisclosureSEC source: 0001283051-26-000015 · wk-form4_1791230735.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,132 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
Mumenthaler Christian StephaneDirector
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0002066326-26-000015 · wk-form4_1791230727.xml · nonDerivative · entry 1 Mumenthaler Christian Stephane · CIK 0002066326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,018 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0001707351-26-000025 · wk-form4_1791230707.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,701 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:05 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001785997-26-000010 · wk-form4_1791230699.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,932 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:04 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0001754648-26-000015 · wk-form4_1791230692.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,929 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:04 UTC |
Seitz MichelleDirector
|
GrantCommon Stock | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001836301-26-000020 · wk-form4_1791230684.xml · nonDerivative · entry 1 Seitz Michelle · CIK 0001836301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,125 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:04 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0002013372-26-000016 · wk-form4_1791230677.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,901 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:04 UTC |
Kennard William EDirector
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0001198236-26-000015 · wk-form4_1791230666.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,248 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:04 UTC |
Glaser Daniel SDirector
|
GrantCommon Stock | 544 | $94.35 | $51,326.40 |
DisclosureSEC source: 0001420864-26-000024 · wk-form4_1791230671.xml · nonDerivative · entry 1 Glaser Daniel S · CIK 0001420864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,249 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 115 | $95.50 | $10,982.50 |
DisclosureSEC source: 0001714199-26-000011 · wk-form4_1789070562.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,695 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
Mumenthaler Christian StephaneDirector
|
GrantCommon Stock | 21 | $95.50 | $2,005.50 |
DisclosureSEC source: 0002066326-26-000013 · wk-form4_1789070551.xml · nonDerivative · entry 1 Mumenthaler Christian Stephane · CIK 0002066326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,474 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 42 | $95.50 | $4,011.00 |
DisclosureSEC source: 0001707351-26-000020 · wk-form4_1789070540.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,157 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 39 | $95.50 | $3,724.50 |
DisclosureSEC source: 0002013372-26-000014 · wk-form4_1789070545.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,357 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
Kennard William EDirector
|
GrantCommon Stock | 294 | $95.50 | $28,077.00 |
DisclosureSEC source: 0001198236-26-000013 · wk-form4_1789070557.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,704 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 157 | $95.50 | $14,993.50 |
DisclosureSEC source: 0001754648-26-000013 · wk-form4_1789070521.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,385 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 618 | $95.50 | $59,019.00 |
DisclosureSEC source: 0001283051-26-000013 · wk-form4_1789070532.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,191 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 59 | $95.50 | $5,634.50 |
DisclosureSEC source: 0001707516-26-000013 · wk-form4_1789070527.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,557 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:01 UTC |
Glaser Daniel SDirector
|
GrantCommon Stock | 10 | $95.50 | $955.00 |
DisclosureSEC source: 0001420864-26-000022 · wk-form4_1789070515.xml · nonDerivative · entry 1 Glaser Daniel S · CIK 0001420864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,705 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:18 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 4,030 | $95.17 | $383,535.10 |
DisclosureSEC source: 0001770295-26-000011 · wk-form4_1788380321.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,350 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:18 UTC |
TADROS RAMYPresident, U.S. Business
|
Tax withholdingCommon Stock | 4,366 | $95.17 | $415,512.22 |
DisclosureSEC source: 0001714199-26-000009 · wk-form4_1788380315.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,580 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:18 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 6,057 | $95.17 | $576,444.69 |
DisclosureSEC source: 0001709116-26-000007 · wk-form4_1788380327.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,137 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:18 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
Tax withholdingCommon Stock | 4,030 | $95.17 | $383,535.10 |
DisclosureSEC source: 0001787586-26-000007 · wk-form4_1788380331.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,716 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:13 UTC |
Mumenthaler Christian StephaneDirector
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0002066326-26-000011 · wk-form4_1781813587.xml · nonDerivative · entry 1 Mumenthaler Christian Stephane · CIK 0002066326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,452 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:13 UTC |
Kennard William EDirector
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0001198236-26-000011 · wk-form4_1781813579.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,410 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:12 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0001707516-26-000011 · wk-form4_1781813571.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,498 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:12 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0001754648-26-000011 · wk-form4_1781813553.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,229 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:12 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0002013372-26-000012 · wk-form4_1781813532.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,318 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:12 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 1,016 | $87.40 | $88,798.40 |
DisclosureSEC source: 0001283051-26-000011 · wk-form4_1781813527.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,573 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:12 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0001707351-26-000016 · wk-form4_1781813520.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,115 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:11 UTC |
Seitz MichelleDirector
|
GrantCommon Stock | 587 | $0.00 | $0.00 |
DisclosureSEC source: 0001836301-26-000016 · wk-form4_1781813514.xml · nonDerivative · entry 1 Seitz Michelle · CIK 0001836301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,581 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:11 UTC |
Glaser Daniel SDirector
|
GrantCommon Stock | 587 | $87.40 | $51,303.80 |
DisclosureSEC source: 0001420864-26-000020 · wk-form4_1781813506.xml · nonDerivative · entry 1 Glaser Daniel S · CIK 0001420864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,695 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:11 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 587 | $0.00 | $0.00 |
DisclosureSEC source: 0001785997-26-000008 · wk-form4_1781813500.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,388 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 169 | $85.57 | $14,461.33 |
DisclosureSEC source: 0001754648-26-000009 · wk-form4_1781208168.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,642 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
Kennard William EDirector
|
GrantCommon Stock | 322 | $85.57 | $27,553.54 |
DisclosureSEC source: 0001198236-26-000009 · wk-form4_1781208163.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,823 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 39 | $85.57 | $3,337.23 |
DisclosureSEC source: 0002013372-26-000010 · wk-form4_1781208157.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,731 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 61 | $85.57 | $5,219.77 |
DisclosureSEC source: 0001707516-26-000009 · wk-form4_1781208151.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,911 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 42 | $85.57 | $3,593.94 |
DisclosureSEC source: 0001707351-26-000014 · wk-form4_1781208145.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,528 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
Mumenthaler Christian StephaneDirector
|
GrantCommon Stock | 20 | $85.57 | $1,711.40 |
DisclosureSEC source: 0002066326-26-000009 · wk-form4_1781208139.xml · nonDerivative · entry 1 Mumenthaler Christian Stephane · CIK 0002066326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,865 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
Glaser Daniel SDirector
|
GrantCommon Stock | 7 | $85.57 | $598.99 |
DisclosureSEC source: 0001420864-26-000018 · wk-form4_1781208133.xml · nonDerivative · entry 1 Glaser Daniel S · CIK 0001420864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,108 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 678 | $85.57 | $58,016.46 |
DisclosureSEC source: 0001283051-26-000009 · wk-form4_1781208127.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,557 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:02 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 127 | $85.57 | $10,867.39 |
DisclosureSEC source: 0001714199-26-000007 · wk-form4_1781208121.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,946 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 10,712 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · derivative · entry 5 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,712 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 10,600 | $0.00 Strike: $46.85 | $0.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,600 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
SaleCommon Stock | 21,312 | $81.59 | $1,738,822.64 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,380 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionCommon Stock | 10,712 | $45.50 | $487,396.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:07 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionCommon Stock | 10,600 | $46.85 | $496,610.00 |
DisclosureSEC source: 0001770295-26-000007 · wk-form4_1780517253.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2026 Filed May 4, 2026 20:06 UTC |
O'Neill Adrienne KarenEVP & Chief Accounting Officer
|
GrantCommon Stock | 12,485 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002083481-26-000006 · wk-form4_1777925165.xml · nonDerivative · entry 1 O'Neill Adrienne Karen · CIK 0002083481 · EVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,042 F1 · price: Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:05 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 721 | $71.17 | $51,313.57 |
DisclosureSEC source: 0001707351-26-000011 · wk-form4_1775246736.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,485 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:05 UTC |
Seitz MichelleDirector
|
GrantCommon Stock | 721 | $0.00 | $0.00 |
DisclosureSEC source: 0001836301-26-000009 · wk-form4_1775246728.xml · nonDerivative · entry 1 Seitz Michelle · CIK 0001836301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 994 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.